Atlas Trials

The Efficacy and Safety of Pomalidomide and Bendamustine With Dexamethasone in Relapsed or Refractory Multiple Myeloma

Clinical trial NCT04762745 · UNKNOWN

Trial details

NCT number
NCT04762745
Sponsor
Sun Yat-sen University
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Relapsed, Refractory, Multiple Myeloma
Start date
2021-02-01
Primary completion
2022-02-01
Enrollment
56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.